Your browser is no longer supported. Please, upgrade your browser.
APM Aptorum Group Limited monthly Stock Chart
Aptorum Group Limited
Index- P/E- EPS (ttm)-0.54 Insider Own26.43% Shs Outstand29.96M Perf Week13.30%
Market Cap85.01M Forward P/E- EPS next Y-0.58 Insider Trans0.00% Shs Float8.57M Perf Month16.81%
Income-15.80M PEG- EPS next Q-0.21 Inst Own0.80% Short Float3.11% Perf Quarter30.05%
Sales0.60M P/S141.68 EPS this Y-21.20% Inst Trans40.31% Short Ratio0.16 Perf Half Y-15.38%
Book/sh0.66 P/B4.00 EPS next Y0.00% ROA-54.00% Target Price- Perf Year-82.95%
Cash/sh0.13 P/C19.77 EPS next 5Y- ROE-67.10% 52W Range1.16 - 18.25 Perf YTD-83.34%
Dividend- P/FCF- EPS past 5Y- ROI-103.00% 52W High-85.53% Beta-
Dividend %- Quick Ratio2.00 Sales past 5Y- Gross Margin-38.00% 52W Low127.59% ATR0.15
Employees36 Current Ratio2.00 Sales Q/Q36.50% Oper. Margin- RSI (14)63.93 Volatility5.73% 5.39%
OptionableNo Debt/Eq0.01 EPS Q/Q71.00% Profit Margin- Rel Volume0.29 Prev Close2.46
ShortableYes LT Debt/Eq0.01 Earnings- Payout- Avg Volume1.71M Price2.64
Recom2.00 SMA2019.67% SMA5014.27% SMA200-23.53% Volume494,317 Change7.32%
Oct-16-20 08:00AM  
Oct-02-20 04:05PM  
Sep-29-20 09:00PM  
Sep-08-20 03:00AM  
Sep-02-20 08:00AM  
Sep-01-20 02:00AM  
Aug-31-20 06:05PM  
Aug-26-20 03:00AM  
Aug-20-20 02:00AM  
Aug-05-20 11:04AM  
Jul-24-20 02:00AM  
Jul-17-20 06:20AM  
Jul-03-20 12:56PM  
Jun-25-20 11:25AM  
Jun-15-20 08:00AM  
May-29-20 08:00AM  
Apr-29-20 08:00AM  
Apr-15-20 08:00AM  
Mar-30-20 08:00AM  
Mar-24-20 04:00PM  
Feb-28-20 01:00PM  
Feb-26-20 09:15AM  
Feb-24-20 06:00AM  
Feb-10-20 08:00AM  
Jan-03-20 05:38AM  
Nov-15-19 08:00AM  
Sep-19-19 08:10AM  
Sep-09-19 06:34AM  
Jul-11-19 08:00AM  
Jul-08-19 08:00AM  
Jun-26-19 11:05AM  
May-22-19 08:00AM  
May-15-19 09:00PM  
May-07-19 07:19AM  
May-06-19 08:00AM  
Apr-30-19 10:42AM  
Apr-24-19 08:00AM  
Apr-15-19 09:55AM  
Apr-01-19 09:30AM  
Mar-08-19 02:49PM  
Mar-04-19 11:26AM  
Feb-25-19 05:28AM  
Dec-07-18 02:07AM  
Feb-28-18 05:20AM  
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly infectious diseases and cancers. Its pipeline through the establishment of drug discovery platforms enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company is also pursuing therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. It also has projects focused on surgical robotics and natural supplement for women undergoing menopause and experiencing related symptoms. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.